منابع مشابه
Frequency of Errors in Clinical Laboratory Practice
Background and Objective: Laboratory errors are one of the major factors that affect the diagnosis, prognosis, treatment and monitoring in patients.The objective of study is to evaluate the frequency and type of errors in different phases of testing at the Pathology Department of the Shalamar Hospital, Lahore and to evaluate the causes of errors. Methods: This observational study was carrie...
متن کاملClinical Practice Guidelines: Principles for Clinical Practice
S5 print and electronic media where they come across lay guidelines; doctors need to inform the patients regarding available treatment alternatives, their potential harms and benefits, where clinical guidelines work as the best available educative tool. CPGs highlight gaps in known literature where treatment recommendations are not clear cut; hence it helps in identifying areas where future res...
متن کاملCOXIBs In Clinical Practice
9. Some studies have observed an increase in cardiovascular risk in patients on COXIBs; this has not been conclusively studied in well designed clinical trials. Caution is warranted; further safety studies are planned. Additional comments and/or reviews provided by: Dr. P. Pollock (Rheum), Dr. J. Sibley (Rheum), Dr. L. Worobetz (Gastroent), Dr. J. Richardson (Pharm), Dr. D. Blackburn (Col. of ...
متن کاملTympanometry in Clinical Practice
Two “must read” articles on the development of clinical tympanometry are Terkildsen and Thomsen (1959) and Terkildsen and Scott-Nielsen (1960). Their interest in estimating middle-ear pressure and in measuring recruitment with the acoustic reflex had a profound effect on the development of clinical instruments. Each time I read these articles, I am struck first by the incredible amount of infor...
متن کاملBevacizumab in clinical practice.
The development of targeted therapies and especially angiogenesis inhibitor drugs is undoubtedly a major advancement in the treatment of cancer in the 21st century. Bevacizumab is a recombinant humanized monoclonal antibody directed against vascular endothelial growth factor that was approved for the treatment of multiple solid tumors, we have reviewed the side effects cited in clinical trials ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Neurology, neuropsychiatry, Psychosomatics
سال: 2011
ISSN: 2310-1342,2074-2711
DOI: 10.14412/2074-2711-2011-352